190 related articles for article (PubMed ID: 19468359)
1. Outcome following radical cystectomy and bladder-preservation therapy in patients with invasive carcinoma of urinary bladder.
Yadav BS; Ghoshal S; Sharma SC
Indian J Urol; 2008 Jan; 24(1):48-53. PubMed ID: 19468359
[TBL] [Abstract][Full Text] [Related]
2. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
[TBL] [Abstract][Full Text] [Related]
3. Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
Gamal El-Deen HS
J Egypt Natl Canc Inst; 2007 Jun; 19(2):133-46. PubMed ID: 19034344
[TBL] [Abstract][Full Text] [Related]
4. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
[TBL] [Abstract][Full Text] [Related]
5. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.
Asadauskiene J; Aleknavicius E; Pipiriene-Zelviene T; Jankevicius F
Medicina (Kaunas); 2010; 46(5):305-14. PubMed ID: 20679745
[TBL] [Abstract][Full Text] [Related]
8. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Chetner MP; Souhami L; Zlotecki RA; Sause WT; True LD
Oncologist; 2000; 5(6):471-6. PubMed ID: 11110598
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
Jiang DM; Jiang H; Chung PWM; Zlotta AR; Fleshner NE; Bristow RG; Berlin A; Kulkarni GS; Alimohamed NS; Lo G; Sridhar SS
Clin Genitourin Cancer; 2019 Feb; 17(1):38-45. PubMed ID: 30686350
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation for organ preservation in the treatment of muscle invasive bladder cancer: Our Institutional Experience.
Gupta S; De S; Leekha N; Sahay SC; Chaudary P; Srinivasan S; Nandy M
Gulf J Oncolog; 2016 Sep; 1(22):55-60. PubMed ID: 28191808
[TBL] [Abstract][Full Text] [Related]
11. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
[TBL] [Abstract][Full Text] [Related]
12. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
Pasquier D; Barney B; Sundar S; Poortmans P; Villa S; Nasrallah H; Boujelbene N; Ghadjar P; Lassen-Ramshad Y; Senkus E; Oar A; Roelandts M; Amichetti M; Vees H; Zilli T; Ozsahin M
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):904-10. PubMed ID: 26104942
[TBL] [Abstract][Full Text] [Related]
13. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.
Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T
Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713
[TBL] [Abstract][Full Text] [Related]
15. Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
Royce TJ; Liu Y; Milowsky MI; Efstathiou JA; Jani AB; Fischer-Valuck B; Patel SA
Clin Genitourin Cancer; 2021 Aug; 19(4):362-368. PubMed ID: 33839040
[TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.
Fellin G; Graffer U; Bolner A; Ambrosini G; Caffo O; Luciani L
Br J Urol; 1997 Jul; 80(1):44-9. PubMed ID: 9240179
[TBL] [Abstract][Full Text] [Related]
17. Transurethral Resection of Bladder Tumor (TUR-BT) then Concomitant Radiation and Cisplatin Followed by Adjuvant Gemcitabine and Cisplatin in Muscle Invasive Transitional Cell Carcinoma (TCC) of the Urinary Bladder.
Ibrahim SM; Abd El-Hafeez ZM; Mohamed EM; Elsharawy IA; Kamal KM
J Egypt Natl Canc Inst; 2007 Mar; 19(1):77-86. PubMed ID: 18839038
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer.
El-Monim HA; El-Baradie MM; Younis A; Ragab Y; Labib A; El-Attar I
Urol Oncol; 2013 Apr; 31(3):359-65. PubMed ID: 21353794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
